In the second session from the Platelet Reactivity Testing Round Table Discussion, the panel discuss The Role of Antiplatelet Therapies in Neuro-endovascular Procedures.
Among the many fascinating points discussed in this session, are a number of key issues including:
||The role of antiplatelet therapy in endovascular procedures – the types of patient populations
||Aneurysm procedures – when to start antiplatelet therapy
||Platelet function tests used to assess the response to clopidogrel
||Response to clopidogrel – complications with this technique
||Percentage inhibition versus PRU to assess the response to drug and platelet reactivity
||Approaching issues of intercranial haemergage risk
Robert Storey, Professor and Honorary Consultant in Cardiology, Department of Cardiovascular Science, University of Sheffield, UK (Chair)
Guillaume Taylor, Département d'Anesthésie Réanimation Urgencies, Fondation Ophtalmologique A de Rothschild, Paris, France
Jeff Daheln, Chief Scientific Officer, Accumetrics, US
Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:
- Increase physician awareness of the multidisciplinary role of antiplatelet therapy
- Increase understanding of the role of platelet function testing in high-risk PCI
- Explain the emerging role of PFT in PAD
- Assess the role of antiplatelets in neuro-endovascular procedures
This round table discussion is intended for an international audience, specifically interventional cardiologists, interventional radiologists and aligned healthcare professional involved with antiplatelet therapy.
The Round Table Event was supported by Accumetrics.